Verified product status
BPC-157 Regulatory and Evidence Status
FDA’s July 2026 advisory materials evaluated BPC-157-related bulk substances for possible inclusion on the 503A Bulks List and proposed that BPC-157 free base and acetate not be included. Advisory recommendations are non-binding; this page does not claim a final rule that the cited record does not establish.
Dated verification
What the reviewed sources establish
A regulatory proposal, advisory recommendation, clinical-development stage and marketing approval are kept as separate findings.
No FDA-approved BPC-157 finished drug identified in the reviewed sources
FDA briefing and compounding materials
FDA proposed not including BPC-157 free base or acetate
July 2026 FDA PCAC presentation
PCAC advice is non-binding and is not itself a final rule
FDA advisory-committee explanation
Status timeline
Keep the date attached to the claim.
Later events do not retroactively change what an earlier source established. This timeline records the source context used for the current wording.
FDA’s category update noted planned PCAC consultation after withdrawal of prior nominations.
PCAC considered BPC-157-related bulk substances; FDA materials proposed not adding the free base or acetate.
Tracker preserves the proposal/advisory boundary and does not assert a later final action.
Entity boundary
The name is not the approval.
Preclinical papers, compounding nominations and catalog availability are not FDA approval. The status also does not convert animal or laboratory findings into established human efficacy.
Research and regulatory information only. No clinical-use or dosing guidance.Primary and technical sources
Records used for this guide
Sources are linked directly so the wording, date and scope can be checked independently.
- 01Source record
July 23–24, 2026 Pharmacy Compounding Advisory Committee Meeting
U.S. FDA. Meeting page, briefing documents and committee materials.
- 02Source record
FDA Briefing Presentation for BPC-157-Related Bulk Drug Substances
U.S. FDA. Recommendation presented July 23, 2026.
Knowledge center